PEAK6 Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-30,400
Closed -$2.25M 4217
2023
Q4
$2.25M Sell
30,400
-2,400
-7% -$157K 0.01% 1422
2023
Q3
$2.24M Buy
32,800
+19,300
+143% +$1.64M 0.01% 1257
2023
Q2
$1.27M Hold
13,500
0.01% 1534
2023
Q1
$915K Sell
13,500
-52,600
-80% -$3.38M ﹤0.01% 1914
2022
Q4
$3.27M Buy
66,100
+21,700
+49% +$887K 0.02% 963
2022
Q3
$1.44M Buy
44,400
+16,200
+57% +$668K 0.01% 1857
2022
Q2
$1.85M Sell
28,200
-30,300
-52% -$1.62M ﹤0.01% 2404
2022
Q1
$4.09M Sell
58,500
-53,200
-48% -$3.89M 0.01% 1249
2021
Q4
$8.69M Sell
111,700
-27,400
-20% -$2.42M 0.02% 797
2021
Q3
$13.3M Buy
139,100
+61,600
+79% +$6.5M 0.03% 576
2021
Q2
$9.63M Sell
77,500
-61,000
-44% -$7.28M 0.02% 708
2021
Q1
$18.3M Sell
138,500
-438,000
-76% -$60M 0.04% 384
2020
Q4
$76.4M Buy
576,500
+20,800
+4% +$2.52M 0.16% 110
2020
Q3
$56.7M Buy
555,700
+383,900
+223% +$33.2M 0.14% 131
2020
Q2
$14.9M Buy
171,800
+115,700
+206% +$9.24M 0.05% 354
2020
Q1
$3.25M Sell
56,100
-137,000
-71% -$11.1M 0.02% 738
2019
Q4
$17.9M Buy
193,100
+66,600
+53% +$5.86M 0.09% 214
2019
Q3
$11.4M Buy
126,500
+7,900
+7% +$900K 0.07% 316
2019
Q2
$14M Buy
118,600
+80,500
+211% +$8.11M 0.09% 245
2019
Q1
$3.3M Sell
38,100
-94,700
-71% -$8.06M 0.02% 952
2018
Q4
$8.38M Buy
132,800
+110,600
+498% +$7.59M 0.05% 399
2018
Q3
$1.75M Buy
+22,200
New +$1.45M 0.01% 1527

Other funds holding EXAS

PEAK6 Investments's EXAS Position: Q2 2024 in Review

PEAK6 Investments sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 4,002 shares — an estimated $276K sold.

PEAK6 Investments first reported a position in EXAS in Q3 2018 and held it in 13 quarters. The position peaked at $9.14M in Q1 2020. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • PEAK6 Investments reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 4,002 Exact Sciences shares in Q2 2024, an estimated $276K.
  • PEAK6 Investments first reported a position in Exact Sciences in Q3 2018 and held it in 13 quarters.
  • PEAK6 Investments's Exact Sciences position peaked at $9.14M in Q1 2020.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.